Explore Company News Direct From Our Network
Global News from Our Network.
Search and filter the results by company or location to find the news that matters to you.
If you would like to publish news on behalf of your company, please register with us at the following link https://www.pharmaservicesdirectory.com/register
Save
This Search |
View as Grid
| Order by Recently Added
| Order
by Company Name
- Total Results: 1,365
- Total Pages: 171
Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub
The PPD™ clinical research business of Thermo Fisher Scientific, has announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub in Gothenburg, Sweden. The partnership aims to leverage the combined expertise of Thermo Fisher and AstraZeneca to drive innovation and strengthen the life science ecosystem. A dedicated team from Thermo Fisher will co-locate with AstraZeneca scientists to work on collaborative R&D projects with a focus initially on chromatography, molecular genomics and proteomics. The AstraZeneca…
Read more on this story »
Partner Profile
Hikma, Celltrion Partner to Expand Biosimilar Reach in MENA
Amman, Oct. 6 (Petra) -- Hikma Pharmaceuticals PLC, the multinational pharmaceutical group, has deepened its collaboration with global biopharmaceutical leader Celltrion Inc through a series of exclusive licensing agreements that will bring advanced, affordable biosimilar medicines to patients across the Middle East and North Africa (MENA) region.The new agreements, announced Monday, pave the way for the launch of six biosimilars, expanding access to cutting-edge treatments in key therapeutic areas, including…
Read more on this story »
Partner Profile
Monash University Malaysia and Tata Chemicals forge healthcare research-focused partnership
The importance of gastrointestinal health is a key focus for researchers and innovators, as highlighted by the partnership between Monash University Malaysia and Tata Chemicals Limited.
Both parties formally established the collaboration through a Memorandum of Agreement (MOA) that set two research projects that connected both academic excellence and industrial innovation. This alliance is dedicated to conducting impactful research in gut microbiome and gut health, aiming to deliver relevant outcomes.
Partner Profile
Cell X Technologies and BioLamina Collaborate to Enhance iPSC Therapeutics Standardization
Cell X Technologies and BioLamina have entered into a collaboration to address challenges in the standardization of induced pluripotent stem cell (iPSC)-based therapeutics. The partnership will combine BioLamina’s Biolaminin® laminin reagents with Cell X’s Celligent
Read more on this story »
Partner Profile
New Partnership Brings Next-Generation Cell Isolation Solutions to Researchers Advancing Cell and Gene Therapy Development
Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to expand access to Akadeum’s next-generation cell isolation technology for cell and gene therapy development.
Partner Profile
Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality
CHICAGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM)
Read more on this story »
Partner Profile
Gattefossé and Ambiotis have explored the role of pro-resolving lipids in skin aging
As skin aging is increasingly seen as a sign of deep biological imbalance, Gattefossé and Ambiotis are joining forces to explore the role of pro-resolving lipids in skin health. Their scientific collaboration paves the way for innovative cosmetic solutions focused on a more integrative approach to aging
View original story »
Partner Profile
HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders
Vienna, Austria – September 23, 2025 – HeartBeat.bio has entered into a research collaboration with Boehringer Ingelheim to develop gene therapy-based treatments for genetic cardiomyopathies. The partnership combines Boehringer Ingelheim’s expertise in gene therapy drug development with HeartBeat.bio’s proprietary Cardioid Drug Discovery Platform, aiming to advance innovative therapies for inherited heart muscle diseases. The partnership addresses a high unmet need in cardiovascular health. Genetic cardiomyopathies - including hypertrophic,…
Read more on this story »
Partner Profile
- Total Results: 1,365
- Total Pages: 171
Network News
Keeping the latest and up-to-date news on our companies is a key activity of the editorial team.
We support companies directly through the profiles to allow them update their profile with the latest news and company announcements. Search fields are provided so that you can access news by company name, sector e.g research, manufacturing, equipment, packaging or geography.
The global news is updated daily and its aim is to provide you as a directory user with the information needed to make good buying or supply choices. News covers companies operating within the pharmaceutical, biotechnology, medical device and nutraceutical sectors.
Also through our software applications you can evaluate, rate and score news and company announcements to support corporate risk management activities. Through the software applications it is possible to supplement and add your own news items, keeping a library of news activities on any company identified through the directory.
Take the Next Step
Should you have any questions or require further information please contact us ...
Contact the support team »
Check if your company is listed and claim your online profile ...
Search for your company listing »
If you're not listed in the directory and you want to build a public profile, register for an account ...
Register for an account to build a profile »
Apply for a free trial of our Supplier Management Software ...
Register for an account to trial the software »
